Sphera Funds Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Buy	+220,000	New	+$1.12M	0.18%	90
2019 Q2	–	Sell	-183,151	Closed	-$1.97M	–	96
2019 Q1	$1.97M	Sell	183,151 -90,000	-33%	-$1.33M	0.27%	86
2018 Q4	$4.13M	Buy	273,151 +40,000	+17%	+$593K	0.6%	49
2018 Q3	$4.31M	Buy	233,151 +150,009	+180%	+$3.42M	0.56%	56
2018 Q2	$1.9M	Sell	83,142 -96,858	-54%	-$2.47M	0.3%	83
2018 Q1	$5.12M	Buy	180,000 +20,000	+13%	+$571K	0.89%	38
2017 Q4	$3.38M	Sell	160,000 -50,000	-24%	-$1.04M	0.54%	62
2017 Q3	$3.82M	Buy	210,000 +10,000	+5%	+$156K	0.68%	52
2017 Q2	$3.1M	Buy	200,000 +50,000	+33%	+$754K	0.63%	56
2017 Q1	$2.59M	Buy	+150,000	New	+$1.97M	0.66%	58